Is Your Oncology Sales Pipeline at Risk? How the Patent Cliff Could Be the Wake-Up Call Your Business Needs
In the rapidly evolving landscape of oncology treatments, one looming threat could spell the difference between sustained growth and sudden decl…
In the rapidly evolving landscape of biopharmaceuticals, the concept of the “patent cliff” isn’t just a looming threat—it’s a strategic battlefield. As blockbuster biologics approach patent expiration, the race to capitalize on biosimilar opportunities…
The $200 Billion Battle Over Bioequivalence: Are Generic Drugs Truly the Same?
Imagine a world where the medications you rely on daily—your blood pressure pills, cholesterol reducers, or pain relievers—are not as identical as they seem. A quiet, yet co…
Prove It’s the Same: The $200 Billion Bioequivalence Fight Reshaping Generic Drugs Read Post »
In the relentless race to bring life-saving drugs to market, the path from lab to patient is often fraught with delays, high costs, and unpredictable hurdles. But what if there was a smarter, more strategic route—one that could streamline development, …
In the high-stakes world of pharmaceutical innovation, the recent passage of the Inflation Reduction Act (IRA) has sent shockwaves through the industry—and for good reason. As the dust begins to settle, one question looms large: What does this mean for…
The IRA Price Reset: What It Actually Does to Pharma Pricing, and What Comes Next Read Post »
In the relentless race to innovate, pharmaceutical companies have long relied on a strategic playbook: the patent wall. This formidable barrier, designed to protect groundbreaking discoveries and maximize profits, often extends the exclusivity of a dru…
When the Patent Wall Crumbles: Secondary Abandonment and the Death of Drug Evergreening Read Post »
In the high-stakes world of pharmaceuticals, innovation alone isn’t enough. The real game-changer lies in how companies identify, secure, and leverage patent licensing opportunities to maximize their market potential and stay ahead of the competition. …
The Strategic Playbook for Identifying and Securing Drug Patent Licensing Opportunities Read Post »
In the relentless race to develop groundbreaking new medicines, the pharmaceutical industry often overlooks a powerful, underutilized strategy: drug repurposing. As highlighted in a compelling article by Drug Patent Watch, the traditional path of disco…
No Patents, No Problem: The Untapped Power of Drug Repurposing Read Post »
In the high-stakes world of pharmaceutical innovation, the race to bring a new drug to market is only part of the story. Equally critical—and often overlooked—is the complex web of secondary patents that can delay generic entry for years, inflating cos…
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
ð¨ Attention Specialty Pharmacies: Are You Ready to Double Your Margins When Generics Hit the Market? ð¨
In the fiercely competitive world of specialty pharmacy, margins are razor-thin, and every percentage point counts. But what if there was a pro…
Double Your Specialty Pharmacy Margins the Day Generics Launch Read Post »
Get new actionable insights and updates from BiotechBlog
